Hematology Today

Hematology Today—June 22, 2026

This week’s Hematology update highlights regulatory milestones, advancing…


Cell and Gene Therapy Today

Cell and Gene Therapy Today—June 18, 2026

This week’s Gene and Cell Therapy update highlights early clinical progress,…


Hematology Today

Hematology Today—June 15, 2026

This week’s Hematology update highlights regulatory actions, clinical progress,…


Cell_Gene_Therapy

Cell and Gene Therapy Today—June 4, 2026

This week’s Cell and Gene Therapy update highlights regulatory progress, early…


Hematology

Hematology Today—June 2, 2026

This week’s Hematology update highlights ASCO 2026 readouts, regulatory…


Hematology

Hematology Today—May 25, 2026

This week’s Hematology update highlights regulatory approvals, reimbursement…


Hematology

Hematology Today—May 18, 2026

This week’s Hematology update highlights regulatory progress, clinical…


Hematology

Hematology Today—May 11, 2026

This week’s Hematology update highlights clinical financing activity, precision…


Hematology

Hematology Today—April 27, 2026

This week’s Hematology update highlights regulatory approvals, extended review…


Cell_Gene_Therapy

Cell and Gene Therapy Today—April 23, 2026

This week’s Gene and Cell Therapy update highlights regulatory momentum,…


LucidWargames_simulation

In Vivo CAR-T: Stress-Testing the Lilly–Kelonia Deal with AI-Powered Wargaming

Why the Lilly–Kelonia Deal Matters for In Vivo CAR-T Download the…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash

Lucid Diligence Brief: Eli Lilly acquires Kelonia for up to $7 billion in cash…


Privacy Preference Center